Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

por Izadi, Zara, Brenner, Erica J., Mahil, Satveer K., Dand, Nick, Yiu, Zenas Z. N., Yates, Mark, Ungaro, Ryan C., Zhang, Xian, Agrawal, Manasi, Colombel, Jean-Frederic, Gianfrancesco, Milena A., Hyrich, Kimme L., Strangfeld, Anja, Carmona, Loreto, Mateus, Elsa F., Lawson-Tovey, Saskia, Klingberg, Eva, Cuomo, Giovanna, Caprioli, Marta, Cruz-Machado, Ana Rita, Mazeda Pereira, Ana Carolina, Hasseli, Rebecca, Pfeil, Alexander, Lorenz, Hanns-Martin, Hoyer, Bimba Franziska, Trupin, Laura, Rush, Stephanie, Katz, Patricia, Schmajuk, Gabriela, Jacobsohn, Lindsay, Seet, Andrea M., Al Emadi, Samar, Wise, Leanna, Gilbert, Emily L., Duarte-García, Alí, Valenzuela-Almada, Maria O., Isnardi, Carolina A., Quintana, Rosana, Soriano, Enrique R., Hsu, Tiffany Y-T., D’Silva, Kristin M., Sparks, Jeffrey A., Patel, Naomi J., Xavier, Ricardo Machado, Marques, Claudia Diniz Lopes, Kakehasi, Adriana Maria, Flipo, René-Marc, Claudepierre, Pascal, Cantagrel, Alain, Goupille, Philippe, Wallace, Zachary S., Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Hausmann, Jonathan S., Liew, Jean W., Sirotich, Emily, Sufka, Paul, Robinson, Philip C., Machado, Pedro M., Griffiths, Christopher E. M., Barker, Jonathan N., Smith, Catherine H., Yazdany, Jinoos, Kappelman, Michael D.
Publicado 2021